跳至主要内容
临床试验/NCT07253428
NCT07253428进行中(未招募)不适用

IMPACT OF SUGAMADEX ON AGITATION UPON EMERGENCE FOLLOWING ADULT NASAL SURGERIES.

Ain Shams University1 个研究点 分布在 1 个国家目标入组 486 人开始时间: 2025年10月30日最近更新:
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
486
试验地点
1
主要终点
the incidence of emergence agitation following adult nasal surgeries in patients receiving sugammadex versus a traditional neuromuscular blocking agent reversal method.

研究概览

简要总结

The impact of sugammadex on agitation upon emergence following adult nasal surgeries is an issue which needs to be studied that links anesthetic management with postoperative recovery.

详细描述

The included patients in the study will not be premedicated by sedatives, they will be preoxygenated for 5 minutes by 100% oxygen. The induction of anesthesia will be by fentanyl 100 microgram, 1.5 mg/kg lidocaine followed by propofol 2mg/kg, and rocuronium 0.5 mg/kg. oral intubation will be commenced and an oral pack will be inserted. Anesthesia will be maintained by sevoflurane 2% and N2O : O2 ratio of 50: 50.

Hypotensive anesthesia will be conducted by labetalol 10- 20 mg i.v. At the end of surgery inhalational anesthesia will be abandoned and muscle relaxant will be antagonized either by sugamadex 1mg/kg or neostigmine 0.05 mg/kg mixed with atropine 0.02 mg/kg. After awakening of the of the patients, emergence agitation will be assessed by Agitation and Emergence Score (AES): This scale is ranging from 0 (calm and cooperative) to 4 (combative, aggressive behavior).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

盲法说明

no need for masking

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients aging from 18 to 60 years old, undergoing nasal surgeries such as septoplasty, FESS or Rhinoplasty
  • ASA I and ASA II

排除标准

  • Patients receiving any medications which may affect recovery state e.g. Antipsychotics.
  • Obstructive sleep apnea patients

研究组 & 干预措施

Sugamadex group

Active Comparator

Sugamadex group will receive sugamadex as a reversal agent of the muscle relaxant; rocuronium

干预措施: Sugamadex (Drug)

Neostigmine group

Other

Neostigmine group will receive the neostigmine as a reversal of the muscle relaxant; rocuronium

干预措施: Neostigmine + Atropine (Drug)

结局指标

主要结局

the incidence of emergence agitation following adult nasal surgeries in patients receiving sugammadex versus a traditional neuromuscular blocking agent reversal method.

时间窗: perioperative

Agitation and Emergence Score (AES): This scale is ranging from 0 (calm and cooperative) to 4 (combative, aggressive behavior).

次要结局

  • duration to full consciousness(Perioperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sabah Nageeb

Lecturer of anesthesia and intensive care

Ain Shams University

研究点 (1)

Loading locations...

相似试验